Safety of olmesartan in a patient with telmisartan‐induced myotoxicity: a case report

E-ISSN： 1365-2125|79|6|1034-1036

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.79, Iss.6, 2015-06, pp. : 1034-1036

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phenotype Standardization for Statin‐Induced Myotoxicity

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 4, 2014-10 ,pp. : 470-476

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letters to the Editor

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 1, 2015-01 ,pp. : 117-118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Making the Business Case for Patient Safety

By Weeks William B. Bagian James P.

Joint Commission Journal on Quality and Patient Safety, Vol. 29, Iss. 1, 2003-01 ,pp. : 51-54

Joint Commission Resources

Access to resources Recommend Favorite

The use and safety of combined resistance and aerobic training in a patient with complications related to type 2 diabetes: a case report

By Otterman Nicoline M. van der Schaaf Marike Busch-Westbroek Tessa E. van Schie Carine H. M. Nollet Frans

Disability and Rehabilitation, Vol. 34, Iss. 17, 2012-08 ,pp. : 1495-1500

Informa Healthcare

Access to resources Recommend Favorite

Case Report of the Safety Assessment of Transcranial Magnetic Stimulation Use in a Patient With Cardiac Pacemaker: To Pulse or Not to Pulse?

HEADACHE, Vol. 58, Iss. 2, 2018-02 ,pp. : 295-297

John Wiley & Sons Inc

Access to resources Recommend Favorite